| Net income | -10.09M |
| Depreciation and amortization | |
| Loss (gain) on disposal of fixed assets | |
| Stock-based compensation expense | 2.78M |
| Deferred compensation | 2.89M |
| Lease termination expense | |
| Amortization of deferred gains | -536K |
| Other | 3.94M |
| Inventories | -75.44M |
| Accounts receivable, prepaid expenses and other assets | |
| Income tax receivable | |
| Accounts payable and accrued expenses | 9.69M |
| Accrued income taxes payable | -6.27M |
| Net cash provided by operating activities | |
| Capital expenditures | -22.78M |
| Proceeds from disposition of properties | 49K |
| Proceeds from sale of restricted assets | 1.91M |
| Purchase of restricted investments | -765K |
| Net cash (used in) provided by investing activities | |
| Purchases of treasury stock | -10.57M |
| Proceeds from stock options exercised, stock purchase plan and other, net | |
| Debt issuance costs | |
| Net cash (used in) provided by financing activities | |
| Change in cash and cash equivalents | -76.88M |
| Cash and cash equivalents at the beginning of the period | |
| Cash and cash equivalents at the end of the period | |